Title: Spirometric Assessment of Pulmonary Function in the Elderly with Ischaemic Heart Disease
Authors: Dr Dileep Rampure, Dr C.Ramakrishna, Dr Ch.Priyanka
DOI: http://dx.doi.org/10.18535/jmscr/v3i10.01
Studies have noted a high incidence of pulmonary function abnormalities in patients with coronary artery disease and no pre-existing pulmonary disease. This impairment function in elderly patients with ischaemic heart disease has not been adequately studied in India.Pulmonary function in the elderly patients with ischaemic heart disease was assessed spirometrically and to detect impaired lung function, if present. Subnormal pulmonary function, as evidenced by FEV1, FVC and PEFR values which were significantly lower than that predicted for normal subjects, was detected in elderly individuals with ischaemic heart disease. The pattern of the pulmonary function defect was of restrictive type in the majority. In this study, FEV1, FVC and PEFR values as a percentage of predicted tended to decline as the number of coronary arteries involved increased. FEV1, FVC and PEFR values as a percentage of predicted tended to increase as the ejection fraction increased. 1. Schroeder EB, Welch V L, Couper D . Lung function and incident coronary heart disease The atherosclerosis risk in communities study. Am J Epidemiol 2003; 158:1171–1181. 2. Sin. DD, Wu LL and Man SFP. The relationship between reduced lung function and cardiovascular mortality -A population-based study and a systematic review of the literature. Chest 2005; 127:1952-1959. 3. Friedman GD, Klatsky AL, Siegelaub AB. Sin DD. and Man SFP .Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976; 294: 1071-1075. 4. Engström G, Hedblad B, Wollmer P .Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: A study from "Men Born in 1914," Malmö, Sweden. Circulation 2001; 103; 3086-3091. 5. Engström G, Hedblad B, Janzon L. Reduced lung function predicts increased fatality in future cardiac events. A population-based study. J Intern Med 2006; 260(6):560-7. 6. Sin DD. and Man SF .Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107; 1514 -1519. 7. G. Engström, P. Lind, B. Hedblad. Lung function and cardiovascular risk: Relationship with inflammation-sensitive plasma proteins. Circulation 2002; 106; 2555-2560.66 8. Sunyer J, Ulrik C.S 2005 Level of FEV1 as a predictor of all-cause and cardiovascular mortality: an effect beyond smoking and physical fitness? Eur Respir J 2005; 25: 587–588. 9. R.P. Young, R. Hopkins and T.E. Eaton. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. EurRespir J 2007; 30: 616–622. 10. Schünemann H J., Dorn J, Grant BJB. Pulmonary function is a long-term predictor of mortality in the general population: 29-year follow-up of the Buffalo Health Study. Chest 2000; 118; 656-664 11. Scanlon PD. Does cardiac dysfunction cause pulmonary restriction? Chest1995; 107; 6-7. 12. Sobol BJ, Herbert WH and Emirgil C. The high incidence of pulmonary functional abnormalities in patients with coronary artery disease. Chest. 1974; 65; 148-151. 13. Canver CC, Nichols RD, Kroncke GM. Influence of age-specific lung function on survival after coronary bypass. Ann Thorac Surg.1998; 66(1):144-7. 14. Miller MR, Hankinson J, Brusasco V. Standardisation of spirometry. Eur Respir J. 2005; 26: 319 – 338. 15. American Thoracic Society. Standardization of spirometry, 1994 update. Am J RespirCrit Care Med 1995; 152 : 1107 – 1136. 16. Hancox B, Whyte K. Pocket Guide to Lung Function Tests, 1st Edition. Sydney. McGraw-Hill; 2001 17. Enright PL, Kronmal RA, Smith V. Reduced Vital Capacity in Elderly Persons With Hypertension, Coronary Heart Disease, or Left Ventricular Hypertrophy: The Cardiovascular Health Study. Chest 1995; 107; 28-35. 18. Jones P. St George’s Respiratory Questionnaire Manual. London: Division of Cardiac and Vascular Science, St George’s University of London; 2008 19. Kamat SR, Tyagi NK, Rushid SA. Lung functions in Indian Adult Subject. Lung India1988; 1:11. 20. Kamat SR, Sarma BS, Raju VR. Indian norms for pulmonary function: observed values prediction equations and intercorrleation. J Assoc Physicians India 1977; 25:531-40. 21. Udwadia FE, Sunavala JD, Shetye VM. The maximal expiratory flow-volume curve in normal subjectsin India. Chest 1986; 89:852-6. 22. Simons LA, McCallum J, Simons J, Friedlander Y. Relationship of peak expiratory flow rate with mortality and ischaemic heart disease in elderly Australians. Med J Aust. 1997; 166(10):526-9. 23. Zureik M; Francine Kauffmann, Pierre-Jean Touboul, Dominique Courbon, BS; Pierre Ducimetière. Association Between Peak Expiratory Flow and the Development of Carotid Atherosclerotic Plaques. Arch Intern Med. 2001; 161:1669-1676. 24. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 2003; 114:758–76. 25. Goswami B, Rajappa M, Mallika V. TNF-alpha/IL-10 ratio and C-reactive protein as markers of the inflammatory response in CAD-prone North India patients with acute myocardial infarction. ClinChim Act 2009; 408(1-2):14-8.Abstract
References